| CXHL2300434 | 盐酸伊立替康脂质体注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(2.2;2.4) | New Drug Application | 2023-04-26 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CYHS2403130 | 盐酸伊立替康脂质体注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2024-09-20 | | Zhejiang Sundoc Pharmaceutical Science And Tech Co Ltd;Zhejiang Hisun Pharmaceutical Co Ltd | | | view |
| CXL01213 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(5) | New Drug Application | 2001-05-11 | 安万特（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Approval | | view |
| JYHB2500229 | 盐酸伊立替康脂质体注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(5.1) | Supplementary Application | 2025-04-22 | | Les Laboratoires Servier Industrie;Ipsen Pharma Biotech | | | view |
| CYHS2101545 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2021-08-10 | | Furen Hetero Onco Therapeutics Ltd | | | view |
| JYHB2300668 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-11-21 | | Pfizer Australia Pty Ltd;Zydus Hospira Oncology Private Ltd | | | view |
| JYHB2200349 | 盐酸伊立替康脂质体注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(5.1) | Supplementary Application | 2022-07-11 | | Les Laboratoires Servier Industrie;Ipsen Pharma Biotech | | | view |
| CYHS2400819 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2024-03-13 | | Fresenius Kabi (Wuhan) Pharmaceutical Co Ltd | | | view |
| CYHL2400136 | 盐酸伊立替康脂质体注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2024-07-08 | | Xi'an Libang Pharmaceutical Co Ltd | | | view |
| JYHB2300060 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-01-20 | | Pfizer Australia Pty Ltd;Pfizer (Perth) Pty Ltd | | | view |
| CYHB2500689 | 盐酸伊立替康脂质体注射液（Ⅱ） | irinotecan hydrochloride | Injection | Chemical Drugs(2.2) | Supplementary Application | 2025-04-07 | | Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | | | view |
| CYHS2101544 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2021-08-10 | | Furen Hetero Onco Therapeutics Ltd | | | view |
| JYHB2300669 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-11-21 | | Pfizer Australia Pty Ltd;Zydus Hospira Oncology Private Ltd | | | view |
| CYHB2200116 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Supplementary Application | 2022-01-14 | | Chengdu Giantech Hi-technology Development Co Ltd;Sichuan Huiyu Pharmaceutical Co Ltd | | | view |
| CXHL2400086 | 盐酸伊立替康脂质体注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(2.4) | New Drug Application | 2024-01-20 | | CSPC OUYI Pharmaceutical Co Ltd | | | view |
| CYHS2401719 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2024-06-07 | | Hefei Yifan Biopharmaceuticals Inc;Lianyungang Zhongwei Biomedical Co Ltd | | | view |
| JYHB2300061 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-01-20 | | Pfizer Australia Pty Ltd;Pfizer (Perth) Pty Ltd | | | view |
| H20020127 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Import Drug Application | 2002-05-30 | 安万特（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
| CXHL2101304 | 盐酸伊立替康脂质体注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(2.2) | New Drug Application | 2021-07-20 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| JYHB2300667 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-11-21 | | Pfizer Australia Pty Ltd;Zydus Hospira Oncology Private Ltd | | | view |
